Outcomes and Complication Rates of Cuff Downsizing in the Treatment of Worsening or Persistent Incontinence After Artificial Urinary Sphincter Implantation

Sylvia Weis; Tim A. Ludwig; Omar Bahassan; Philipp Gild; Malte W. Vetterlein; Margit Fisch; Roland Dahlem; Valentin Maurer

doi:10.5213/inj.2346030.015

추천

검색

자료유형: 학술저널

저자정보: Sylvia Weis (Department of Urology University Medical Center Hamburg-Eppendorf) Tim A. Ludwig (Department of Urology University Medical Center Hamburg-Eppendorf) Omar Bahassan (Department of Urology University Medical Center Hamburg-Eppendorf) Philipp Gild (Department of Urology University Medical Center Hamburg-Eppendorf) Malte W. Vetterlein (Department of Urology University Medical Center Hamburg-Eppendorf) Margit Fisch (Department of Urology University Medical Center Hamburg-Eppendorf) Roland Dahlem (Department of Urology University Medical Center Hamburg-Eppendorf) Valentin Maurer (Department of Urology University Medical Center Hamburg-Eppendorf)

저널정보: 대한배뇨장애요실금학회 International Neurourology Journal International Neurourology Journal 제27권 제2호

발행연도: 2023.6

수록면: 139 - 145 (7page)

DOI: 10.5213/inj.2346030.015

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Purpose: This study investigated the functional outcomes and complication rates of cuff downsizing for the treatment of re current or persistent stress urinary incontinence (SUI) in men after the implantation of an artificial urinary sphincter (AUS). Methods: Data from our institutional AUS database spanning the period from 2009 to 2020 were retrospectively analyzed. The number of pads per day was determined, a standardized quality of life (QoL) questionnaire and the International Consul tation on Incontinence Questionnaire (ICIQ) were administered, and postoperative complications according to the Clavien Dindo classification were analyzed. Results: Out of 477 patients who received AUS implantation during the study period, 25 (5.2%) underwent cuff downsizing (median age, 77 years; interquartile range [IQR], 74–81 years; median follow-up, 4.4 years; IQR, 3–6.9 years). Before downsiz ing, SUI was very severe (ICIQ score 19–21) or severe (ICQ score 13–18) in 80% of patients, moderate (ICIQ score 6–12) in 12%, and slight (ICIQ score 1–5) in 8%. After downsizing, 52% showed an improvement of >5 out of 21 points. However, 28% still had very severe or severe SUI, 48% had moderate SUI, and 20% had slight SUI. One patient no longer had SUI. In 52% of patients, the use of pads per day was reduced by ≥50%. QoL improved by >2 out of 6 points in 56% of patients. Com plications (infections/urethral erosions) requiring device explantation occurred in 36% of patients, with a median time to event of 14.5 months. Conclusions: Although cuff downsizing carries a risk of AUS explantation, it can be a valuable treatment option for selected patients with persistent or recurrent SUI after AUS implantation. Over half of patients experienced improvements in symp toms, satisfaction, ICIQ scores, and pad use. It is important to inform patients about the potential risks and benefits of AUS to manage their expectations and assess individual risks.

#AMS 800 #Artificial urinary sphincter #Reconstructive urology #Stress urinary incontinence #Cuff downsizing

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!